- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07653763
Effect of Virtual Reality During Femoral Sheath Removal
The Effect of Virtual Reality Glasses During Femoral Sheath Removal on Pain, Anxiety, and Vital Signs in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Percutaneous coronary intervention is a commonly used invasive procedure in the diagnosis and treatment of coronary artery disease. Femoral sheath removal performed after the procedure may cause pain, anxiety, and hemodynamic changes in patients. Non-pharmacological interventions are increasingly used to improve patient comfort and reduce procedure-related stress.
Virtual reality technology is considered an effective distraction method that may reduce pain perception and anxiety by directing patients' attention to immersive visual and auditory stimuli. Previous studies have demonstrated the positive effects of virtual reality applications during invasive and painful procedures.
This randomized controlled study aimed to investigate the effect of virtual reality glasses used during femoral sheath removal on pain, anxiety, and vital signs in patients undergoing percutaneous coronary intervention. Patients were randomly assigned to either the intervention group receiving virtual reality application during femoral sheath removal or the control group receiving standard care. Pain intensity, anxiety levels, and vital signs were evaluated before, during, and after the procedure.
The findings of this study may contribute to evidence-based nursing interventions aimed at improving patient comfort during femoral sheath removal procedures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hatay
-
İskenderun, Hatay, Turkey (Türkiye)
- İskenderun Devlet Hastanesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged 18 years and older
- Patients undergoing percutaneous coronary intervention via femoral access
- Patients with only one femoral sheath catheter
- Patients who did not receive analgesic medication before sheath removal
- Patients without severe hemorrhage or major hematoma at the femoral sheath site
- Patients able to communicate in Turkish
- Patients without visual, hearing, or speech impairment
- Patients without mental impairment affecting communication
- Patients without psychiatric diagnosis and not using psychiatric medication
Exclusion Criteria:
Patients unwilling to participate or wishing to withdraw from the study at any stage
- Patients who removed the virtual reality glasses during the intervention
- Patients who experienced intolerance to virtual reality application (e.g., dizziness or nausea)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality Group
Participants received virtual reality glasses during femoral sheath removal
|
Virtual reality glasses were used during femoral sheath removal.
|
|
Other: Control Group
Participants received routine care during femoral sheath removal
|
Participants received routine care during femoral sheath removal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate
Time Frame: Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
|
Heart rate was measured in beats per minute using routine monitoring.
|
Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
|
|
Blood Pressure
Time Frame: Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
|
Systolic blood pressure and diastolic blood pressure were measured in mmHg using routine monitoring.
|
Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
|
|
Oxygen Saturation
Time Frame: Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
|
Oxygen saturation was measured as percent saturation using pulse oximetry.
|
Periprocedural (5 minutes before sheath removal, 5 and 15 minutes after sheath removal)
|
|
Body Temperature
Time Frame: 5 minutes before femoral sheath removal, 5 minutes after femoral sheath removal, and 15 minutes after femoral sheath removal
|
Body temperature was assessed using routine vital sign monitoring.
|
5 minutes before femoral sheath removal, 5 minutes after femoral sheath removal, and 15 minutes after femoral sheath removal
|
|
Pain Level
Time Frame: 5 minutes before femoral sheath removal, 5 minutes after femoral sheath removal, and 15 minutes after femoral sheath removal
|
Pain level was assessed using the Numeric Rating Scale (NRS).
The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates severe pain.
Higher scores indicate greater pain severity.
|
5 minutes before femoral sheath removal, 5 minutes after femoral sheath removal, and 15 minutes after femoral sheath removal
|
|
Anxiety Level
Time Frame: Before femoral sheath removal during completion of the participant information form, and 15 minutes after femoral sheath removal
|
Anxiety level was assessed using the State Anxiety Inventory (STAI).
Higher scores indicate higher anxiety levels.
|
Before femoral sheath removal during completion of the participant information form, and 15 minutes after femoral sheath removal
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HKU-2025/069
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Percutaneous Coronary Intervention
-
Ospedale della MisericordiaUnknownTo Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study (EREMUS)Percutaneous Coronary Intervention | Angioplasty, Transluminal, Percutaneous CoronaryItaly
-
Ospedale Sandro Pertini, RomaCompletedPercutaneous Coronary Intervention | Coronary AngiographyItaly
-
Shenzhen Institute of Advanced Biomedical Robot...Not yet recruitingPercutaneous Coronary InterventionChina
-
Shenyang Northern HospitalCompletedPercutaneous Coronary InterventionChina
-
Beijing Anzhen HospitalPeking UniversityUnknownPercutaneous Coronary Intervention
-
Assiut UniversityUnknownPercutaneous Coronary Intervention
-
ZhangWenduoUnknownPercutaneous Coronary InterventionChina
-
University Hospital of FerraraCompletedPercutaneous Coronary Intervention | Coronary PhysiologyItaly
-
Riphah International UniversityNot yet recruitingPercutaneous Coronary Intervention
-
Asan Medical CenterLN RoboticsCompletedPercutaneous Coronary InterventionKorea, Republic of
Clinical Trials on Virtual Reality
-
Institut National de la Santé Et de la Recherche...RecruitingSchizophrenia | Bipolar DisorderFrance
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
The University of Hong KongCompleted
-
University of PennsylvaniaRecruiting
-
Istanbul University - CerrahpasaCompletedCancer | AnxietyTurkey
-
Cihat OzyılmazCompletedChild | Anxiety | FearTurkey
-
National University of MalaysiaRecruitingPleural EffusionMalaysia
-
Stanford UniversityTerminatedConversion Disorder | Non-epileptic Seizures | Functional Neurological Disorder | Functional Movement Disorder | Psychogenic Movement DisorderUnited States
-
University of WashingtonNational Institutes of Health (NIH); University of Texas; National Institute...Completed
-
Children's Hospital Los AngelesNot yet recruitingProcedural Pain | Procedural Anxiety